GM-CSF administration augments the survival of ity-resistant A/J mice, but not ity-susceptible C57BL/6 mice, to a lethal challenge with Salmonella typhimurium

J Immunol. 1990 Jan 15;144(2):557-61.

Abstract

Ity resistant A/J mice were challenged with a lethal dose (2 x 10(3) organisms) of Salmonella typhimurium. Infected mice treated with 1 microgram of GM-CSF twice daily showed increased median survival time and had a higher survival fraction than untreated controls. GM-CSF was most effective when given for a brief period (1 to 2 days) after infection. Pretreatment of the mice or delayed treatment with GM-CSF had no effect on the survival of the mice. Studies on the effect of GM-CSF on the bacterial load showed that mice treated with GM-CSF had fewer S. typhimurium in the spleen and peritoneal cavity on day 4 but not on day 2 after infection. GM-CSF treatment of ity-susceptible C57BL/6 mice infected with 10 organisms had no therapeutic effect.

MeSH terms

  • Animals
  • Colony-Stimulating Factors / therapeutic use*
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Growth Substances / therapeutic use*
  • Mice
  • Mice, Inbred A / immunology*
  • Mice, Inbred C57BL / immunology*
  • Peritoneal Cavity / microbiology
  • Salmonella Infections, Animal / genetics
  • Salmonella Infections, Animal / immunology*
  • Salmonella Infections, Animal / microbiology
  • Spleen / microbiology
  • Survival Analysis

Substances

  • Colony-Stimulating Factors
  • Growth Substances
  • Granulocyte-Macrophage Colony-Stimulating Factor